Colon News and Research

RSS

Novel drug could help to fight both COVID-19 and cancer

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot get vaccinated or in the event that dangerous new strains of the virus arise that could bypass vaccine protection.

14 Nov 2022

Popular dietary supplement linked to cancer risk, brain metastasis

Well-equipped gut-friendly bacteria hold promise for improving IBD treatments

Like elite firefighters headed into the wilderness to combat an uncontrolled blaze, probiotic bacteria do a better job quelling gut inflammation when they're equipped with the best gear.

11 Nov 2022

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development

A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.

11 Nov 2022

New CRISPR approach is a leap forward in developing personalized treatment for cancer

For the first time, scientists have used CRISPR technology to insert genes that allow immune cells to focus their attack on cancer cells, potentially leaving normal cells unharmed and increasing the effectiveness of immunotherapy.

10 Nov 2022

Understanding the gut-brain connection in metabolic and neurological disorders

The community of microorganisms living in the human gut, known as the gut microbiome, is increasingly recognized as playing a pivotal role in metabolic conditions such as obesity and neurological diseases including Parkinson's disease.

9 Nov 2022

Researchers discover residual tumor cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum.

9 Nov 2022

UAB researchers report lack of predictability for fecal microbial transplants without prior antibiotic therapy

A fecal microbial transplant - giving a recipient fecal matter from a donor to change the recipient's gut microbial community in the colon - has been a successful last resort therapy for people with recurrent Clostridium difficile infection after multiple rounds of suppressive antibiotics have eliminated the recipient microbial community.

4 Nov 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System.

From Beckman Coulter Life Sciences 4 Nov 2022

Fermented dairy products can improve gut mucosal immunity

In a recent study published in the journal Immunology Letters, researchers assessed the role of fermented dairy products and dairy starters in modulating gut mucosal immunity.

3 Nov 2022

Vimentin is an important co-receptor for SARS-CoV-2 infection

Vimentin functions as a co-receptor for the entry of SARS-CoV-2 into host cells to facilitate infection.

2 Nov 2022

Researchers study the unique adaptability of small intestinal bacteria for the first time

Bacteria in the small intestine adapt dynamically to our nutritional state, with individual species disappearing and reappearing.

1 Nov 2022

First preclinical model to study the pathobiology of appendiceal cancer

Appendiceal cancer (malignancies of the appendix, a small tissue pouch that is part of the gastrointestinal tract) is very rare, occurring in perhaps one or two people per 1 million per year.

1 Nov 2022

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

In a new study, researchers assessed the risk of colorectal cancer (CRC) with the intake of flavonoids.

31 Oct 2022

Does maternal obesity impact fetal brain development?

In a new study, researchers assessed the impact of maternal obesity on brain development in the fetus.

31 Oct 2022

UK Markey Cancer Center earns the rigorous NAPRC accreditation

The University of Kentucky Markey Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer.

28 Oct 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Newly developed chemical compounds show promise as potential anticancer therapy

A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.

27 Oct 2022

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

27 Oct 2022

Colon News and Research

Novel drug could help to fight both COVID-19 and cancer

Popular dietary supplement linked to cancer risk, brain metastasis

Well-equipped gut-friendly bacteria hold promise for improving IBD treatments

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development

New CRISPR approach is a leap forward in developing personalized treatment for cancer

Understanding the gut-brain connection in metabolic and neurological disorders

Researchers discover residual tumor cells responsible for colon cancer relapse

UAB researchers report lack of predictability for fecal microbial transplants without prior antibiotic therapy

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

Fermented dairy products can improve gut mucosal immunity

Vimentin is an important co-receptor for SARS-CoV-2 infection

Researchers study the unique adaptability of small intestinal bacteria for the first time

First preclinical model to study the pathobiology of appendiceal cancer

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

Does maternal obesity impact fetal brain development?

UK Markey Cancer Center earns the rigorous NAPRC accreditation

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Commensal gut microbes from IBD patients produce genotoxic metabolites

Newly developed chemical compounds show promise as potential anticancer therapy

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News